Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East: Gulf Survey of Atrial Fibrillation Events

Angiology

Volumn 66, Issue 5, 2015, Pages 464-471

  Zubaid, Mohammad ^a   Rashed, Wafa A ^b   Alsheikh Ali, Alawi A ^c,d   Al Zakwani, Ibrahim ^e,f   AlMahmeed, Wael ^c   Shehab, Abdullah ^g   Sulaiman, Kadhim ^h   Qudaimi, Ahmed Al ⁱ   Asaad, Nidal ^j   Amin, Haitham ^k  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MUBARAK AL KABEER HOSPITAL   (Kuwait)

^c SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SULTAN QABOOS UNIVERSITY   (Oman)

^f Gulf Health Research   (Oman)

^g UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^h ROYAL HOSPITAL   (Oman)

ⁱ Al Thawra Hospital   (Yemen)

^j HAMAD MEDICAL CORPORATION   (Qatar)

^k Mohammed Bin Khalifa Cardiac Centre   (Bahrain)

more..

Author keywords

anticoagulation; atrial fibrillation; Middle East; risk assessment; stroke

Indexed keywords

AMIODARONE; CREATININE; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; HYPERTENSION; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; NONVALVULAR ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; SINUS RHYTHM; TRANSIENT ISCHEMIC ATTACK; ATRIAL FIBRILLATION; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; EMERGENCY HEALTH SERVICE; HOSPITAL DISCHARGE; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PROSPECTIVE STUDY; REGISTER; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STROKE; TIME; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; MIDDLE AGED; MIDDLE EAST; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT DISCHARGE; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 84928010789     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714536980     Document Type: Article

References (31)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991 ; 22 (8). 983-988
2. Vidaillet H, Granada JF, Chyou PH, et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med. 2002 ; 113 (5). 365-370
3. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation. 2004 ; 109 (23). 2839-2843
4. Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ.. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004 ; 90 (3). 286-292
5. de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA.. Rate vs. rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med. 2005 ; 165 (3). 258-262
6. Hart RG, Pearce LA, Aguilar MI.. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillation. Ann Intern Med. 2007 ; 146 (12). 857-867
7. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 ; 361 (12). 1139-1151
8. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010 ; 31 (19). 2369-2429
9. Kerr CR, Boone J, Connolly SJ, et al. The Canadian registry of atrial fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. Am J Cardiol. 1998 ; 82 (8A). 82N - 85N
10. Friberg L, Niklas H, Hans P, Marten R. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J. 2007 ; 28 (19). 2346-2353
11. Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial fibrillation management: a prospective survey in ESC member countries. The Euro heart survey. Eur Heart J. 2005 ; 26 (22). 2422-2434
12. Camm AJ, Breithardt G, Crijns H, et al. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol. 2011 ; 58 (5). 493-501
13. Potpara TS, Vasiljevic ZM, Vujisic-Tesic BD, et al. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade atrial fibrillation study. Chest. 2011 ; 140 (4). 902-910
14. Reiffel JA, Kowey PR, Myerburg R, et al. Practice patterns among United States cardiologists for managing adults with atrial fibrillation. (AFFECTS). Am J Cardiol. 2010 ; 105 (8). 1122-1129
15. Hersi A, Alsheikh-Ali AA, Zubaid M, Al Suwaidi J.. Prospective observational studies of the management and outcomes in patients with atrial fibrillation: a systematic review. J Saudi Heart Assoc. 2012 ; 24 (4). 243-252
16. Lip GY, Brechin CM, Lane DA.. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012 ; 142 (6). 1489-1498
17. Piccini JP, Fraulo ES, Ansell JE, et al. Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J. 2011 ; 162 (4). 606-612
18. Kakkar AK, Mueller I, Bassand JP, et al. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J. 2012 ; 163 (1). 13-19
19. Zubaid M, Rashed WA, Alsheikh-Ali AA, et al. Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Investigators. Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation in the Arab Middle East. Circ Cardiovasc Qual Outcomes. 2011 ; 4 (4). 477-482
20. McNamara RL, Brass LM, Drozda JP Jr, et al. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on clinical data standards (writing committee to develop data standards on atrial fibrillation). Circulation. 2004 ; 109 (25). 3223-3243
21. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ.. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA. 2001 ; 285 (22). 2864-2870
22. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010 ; 137 (2). 263-272
23. Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User's Guide. 2nd ed. (Prepared by Outcome DEcIDE Center [Outcomes Sciences, Inc d/b/a Outcome] under contract No. HHSA290200500351T03.) AHRQ publication No. 10-EHC049. Rockville, MD: Agency for Healthcare Research and Quality; 2010.
24. United Nations. World Population Prospects: The 2008 Revision; Vol. II: Sex and Age Distribution of Populations. United Nations Publication, ST/ESA/SER.A/291. New York: United Nations; 2008
25. Al Rashdan I, Al Nesef Y. Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology. 2010 ; 61 (1). 42-48
26. Huxley RR, Lopez FL, Folsom AR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study. Circulation. 2011 ; 123 (14). 1501-1508
27. Lubitz SA, Yin X, Fontes JD, et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA. 2010 ; 304 (20). 2263-2269
28. Rich DQ, Mittleman MA, Link MS, et al. Increased risk of paroxysmal atrial fibrillation episodes associated with acute increases in ambient air pollution. Environ Health Perspect. 2006 ; 114 (1). 1120-123
29. Ringborg A, Nieuwlaat R, Lindgren P, et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace. 2008 ; 10 (4). 403-411
30. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007 ; 146 (12). 857-867
31. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost. 2012 ; 107 (6). 1172-1179